Compliance with Regulations
Pharmaquinone® Products are identical to already authorised under Regulation 258/1997/EC novel foods and these authorizations are not data protected according to the requirements of Article 26 of Regulation EU 20015/2283. Therefore Pharmaquinone® Products have been placed in the EU market without a dedicated application. The specifications and conditions of use of Pharmaquinone® Productsare in line with the authorised specifications and conditions of use as set out in the Union list of authorised novel foods and/or the implementing Regulations authorizing these substances in accordance to COMMISSION IMPLEMENTING REGULATION (EU) 2018/1023 of 23 July 2018 correcting Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods.

To whom it may concern,

Pharmaquinone® Product, Vitamin K2 as MK-7 is a generic of the well-established and safe for human consumption original active ingredient, which has achieved GRAS in USA and novel food status in EU.The product is intended for use in the manufacturing of food products, including food supplements. Our process ensures the best quality and accordance to European novel food specification, being accepted by the Health Authorities as a reference for the manufacturers.
Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

Free from allergens in compliance with EU Directive 1169/2011 Annex II

To whom it may concern,

In compliance with EU Directive 1169/2011 Annex II
1. Cereals containing gluten
2. Crustaceans and products thereof
3. Eggs and products thereof
4. Fish and products thereof
5. Peanuts and products thereof
6. Soybeans and products thereof
7. Milk and products thereof (including lactose)
8. Nuts and products thereof
9. Celery and products thereof
10. Mustard and products thereof
11. Sesame seeds and products thereof
12. Sulphur dioxide and sulphites at concentrations of more than 10 mg/kg or 10 mg/liter expressed as SO2
13. Lupin and products thereof
14. Molluscs and products thereof

Your faithfully,
Name: Elżbieta Filutowska
Designation: Quality Department

* <A novel method for the determination of chemical purity and assay of menaquinone-7. Comparison with the methods from the official USP monograph> by Jedynak et al.
** BILE TOLERANT GRAM NEGATIVE BACTERIA INCLIDE ENTEROBACTERIACEAE, PSEUDOMONAS AND AEROMONAS
*** EVERY THIRD BATCH IS TESTED

The only „Single peak” vitamin K2

* <A novel method for the determination of chemical purity and assay of menaquinone-7. Comparison with the methods from the official USP monograph> by Jedynak et al.
** BILE TOLERANT GRAM NEGATIVE BACTERIA INCLIDE ENTEROBACTERIACEAE, PSEUDOMONAS AND AEROMONAS

No components need to be disclosed according to the applicable regulations.

Symptoms: (Further) symptoms and / or effects are not known so far.

Treatment: Symptomatic treatment (decontamination, vital functions).

Suitable extinguishing media: water spray, carbon dioxide, dry powder, foam.Unsuitable extinguishing media for safety reasons: water jet .

Endangering substances: carbon oxides, harmful vapours.Advice: The substances/groups of substances mentioned can be released in case of fire.

Special protective equipment:Wear a self-contained breathing apparatus.

Do not spray water directly on fire, product will float and could be reignited on surface of water. Disposeof fire debris and contaminated extinguishing water in accordance with official regulations. Coolendangered containers with water-spray.

Use personal protective clothing. Information regarding personal protective measures, see section 8.Ensure adequate ventilation. Avoid contact with the skin, eyes and clothing.

Do not discharge into drains/surface waters/groundwater. Inform authorities in the event of productspillage to water courses or sewage systems.

For small amounts: Contain with absorbent material (e.g. sand, silica gel, acid binder, general purposebinder, sawdust).For large amounts: Dike spillage. Pump off product.Dispose of absorbed material in accordance with regulations.

Information regarding exposure controls/personal protection and disposal considerations can befound in section 8 and 13.

Handle in accordance with good industrial hygiene and safety practice.Protection against fire and explosion:
Avoid all sources of ignition: heat, sparks, open flame. Take precautionary measures against staticdischarges.

Keep container tightly closed, may be stored in temperatures between 15 °C and 25 °C (RH: 30-50%).Further information on storage conditions: Protect from the effects of light.Storage class according to TRGS 510 (originally VCI, Germany): (10) Combustible liquids.

For the relevant identified use(s) listed in Section 1 the advice mentioned in this section 7 is to beobserved.

Handle in accordance with good industrial hygiene and safety practice. Wearing of closed work clothingis recommended. No eating, drinking, smoking or tobacco use at the place of work. Hands and/or faceshould be washed before breaks and at the end of the shift. Store work clothing separately.

No hazardous reactions if stored and handled as prescribed/indicated.
Corrosion to metals: Corrosive effects to metal are not anticipated

The product is stable if stored and handled as prescribed/indicated.

No dangerous reaction known under conditions of normal use.

Protect from light. Avoid all sources of ignition: heat, sparks, open flame.

Strong oxidizing agents. This product may react with strong alkalies.

No hazardous decomposition products if stored and handled as prescribed/indicated.

There is a high probability that the product is not acutely harmful to aquatic organisms. The inhibitionof the degradation activity of activated sludge is not anticipated when introduced to biologicaltreatment plants in appropriate low concentrations. The product has not been tested. The statementhas been derived from the properties of the individual components

Biodegradable

Accumulation in organisms is not to be expected.

Adsorption in soil: No data available.

According to Annex XIII of Regulation (EC) No.1907/2006 concerning the Registration, Evaluation,Authorization and Restriction of Chemicals (REACH): The product does not contain a substancefulfilling the PBT (persistent/bioaccumulative/toxic) criteria or the vPvB (very persistent/verybioaccumulative) criteria. Self-classification

Product does not contain a substance above legal limits included in the list established in accordancewith Article 59(1) of Regulation (EC) No 1907/2006 for having endocrine disrupting properties or isidentified to have endocrine disrupting properties in accordance with the criteria set out in CommissionDelegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.

The product does not contain substances that are listed in Regulation (EC) 1005/2009 on substancesthat deplete the ozone layer.

Observe national and local legal requirements.

Contaminated packaging:
Uncontaminated packaging can be re-used.
Packs that cannot be cleaned should be disposed of in the same manner as the contents

No data available

Generic authorizations of Novel Foods:
Authorizations are no longer individual. Instead, authorized novel foods are added to the EU list, which serves as a so-called ‘positive list’. Every food business operator that complies with the conditions ofthe authorization can place the respective novel food on the market. Also the applicant-specific novel food authorizations under the old Regulation have been included in the European Union list. This led to an initial list containing 125 entries (numbers as mentioned on the website of the European Commission).

Any other intended applications should be discussed with the manufacturer.

ADR = The European Agreement concerning the International Carriage of Dangerous Goods by Road. ADN = The European Agreement concerning the International Carriage of Dangerous Goods by Inland waterways. ATE = Acute Toxicity Estimates. CAO = Cargo Aircraft Only. CAS = Chemical Abstract Service. CLP = Classification, Labelling and Packaging of substances and mixtures. DIN = German national organization for standardization. DNEL = Derived No Effect Level. EC50 = Effective concentration median for 50% of the population. EC = European Community. EN = European Standards. IARC =International Agency for Research on Cancer. IATA = International Air Transport Association. IBC-Code= Intermediate Bulk Container code. IMDG = International Maritime Dangerous Goods Code. ISO =International Organization for Standardization. STEL = Short-Term Exposure Limit. LC50 = Lethal concentration median for 50% of the population. LD50 = Lethal dose median for 50% of the population. TLV = Threshold Limit Value. MARPOL = The International Convention for the Prevention of Pollution from Ships. NEN = Dutch Norm. NOEC = No Observed Effect Concentration. OEL = Occupational Exposure Limit. OECD = Organization for Economic Cooperation and Development. PBT = Persistent, Bioaccumulative and Toxic. PNEC = Predicted No Effect Level. PPM = Parts per million. RID = The European Agreement concerning the International Carriage of Dangerous Goods by Rail. TWA = Time Weight Average. UN-number = UN number at transport. vPvB = very Persistent and very Bioaccumulative.

The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide.
The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions.
It does not represent any guarantee of the properties of other product. VitaSynth shall not be held liable for any damage resulting from handling or from contact with the above product.

To whom it may concern,

We hereby confirm our various Menaquinone-7 products has been shipped to USA market under FDA supervision for several years. As a result, our Menaquinone-7 dilutions preparation site (sister company):

Europharma Alliance sp. z o. o.AL. LED 1, 55-020 Rzeplin, Poland

has been audited by FDA on 9th and 10th of October, 2019. It was a comprehensive surveillance inspection of foreign dietary supplement raw material manufacturer conducted in accordance with PAC0314, CGMP/Limited Scope PCHF Inspections, with Operation ID 126761. This inspection covered manufacturing of Vitamin K2 bulk premix as dietary ingredient requiring further processing. Inspection of raw ingredient/material receiving, quarantine, batch production, master manufacturing records, sanitation, quality and complaints produced 0 FDA 483 Inspectional Observations. No complaints regarding the firm were found in FACTS. FDA “closed” inspection under 21 CFR 20.64(d)(3).

Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

To whom it may concern,

VitaSynth sp. z o. o. takes every precaution to manufacture and provide safe and functional product range under the trademark: Pharmaquinone®, Vitamin K2 as MK-7 used in the food and chemical industry.
‍
To the best of our knowledge, the product listed above is not derived from genetically modified starting raw materials, or additives that are derived from genetically modified organisms, and do not contain detectable levels of genetically modified materials (known as PCR negative) in compliance with EU Regulation No 1829/2003, including amended EU Directive 2001/18/EC.
‍
Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

To whom it may concern,

VitaSynth sp. z o. o. takes every precaution to manufacture and provide safe and functional product range under the trademark: Pharmaquinone®, Vitamin K2 as MK-7 used in the food and chemical industry.
‍
The manufacturing process does not use any ingredient of animal origin nor do our products come in contact with animal products during storage and transportation. To the best of our knowledge, the product listed above is free from Transmissible Spongiform Encephalopathy (TSE) and Bovine Spongiform Encephalopathy (BSE) in compliance with good manufacturing practice and EU Regulation (EC) No 999/2001.
‍
Yours faithfully,

Name: Elżbieta Filutowska
Designation: Quality Department

• Product Identity and Form
• Responsible for Product Development, Research and Regulatory Affairs
• Manufacturing and Quality Assurance/Quality Control Information
• Lot Number System, Product Storage, Packaging and Labelling Information
• Certifications and Compliance
• Regulatory Status and IPR
• Food Safety System
• Origin and Composition
• Nutritional Profile*
• Allergens on Production Line
• Free from Allergen Statement
• Product Specification
• Certificate of Analysis
• Flowchart
• Safety Data Sheet
• Attachments